hrs/ehra/ecas consens us statement on catheter and surgical ablation of atrial fibrillation
DESCRIPTION
HRS/EHRA/ECAS Consens us Statement on Catheter and Surgical Ablation of Atrial Fibrillation. K.R. Julian Chun. Asklepios Klink St. Georg, Hamburg. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation. Fuster et al. Circulation 2006;114: 257-354. - PowerPoint PPT PresentationTRANSCRIPT
HRS/EHRA/ECAS ConsensHRS/EHRA/ECAS Consensus us
Statement on Catheter and Surgical Statement on Catheter and Surgical
Ablation of Atrial Fibrillation Ablation of Atrial Fibrillation
Asklepios Klink St. Georg, HamburgAsklepios Klink St. Georg, Hamburg
K.R. Julian ChunK.R. Julian Chun
ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation
Fuster et al. Circulation 2006;114: 257-354
Verma A et al. (Circulation 2005;112:1214–1231)
Catheter ablatioCatheter ablation of atrial fibrillationn of atrial fibrillation
SUCCESS RATES
Verma A et al. (Circulation 2005;112:1214–1231)
Catheter ablatioCatheter ablation of atrial fibrillationn of atrial fibrillation
COMPLICATIONS – LARGE Centers
Pooled data complication rate: 2.8%
COMPLICATIONS - World Wide Survey
Cappato et al. Circulation 2005; 111; 1100-1105
Catheter ablatioCatheter ablation of atrial fibrillationn of atrial fibrillation
%n=
1990 1995 2000 2005 2010 2015 2020 2025 2030 2035 2040 2045 2050
2.262.44
2.662.94
3.33
3.80
4.34
4.78
5.165.42
5.61
7.0
6.0
5.0
4.0
3.0
2.0
1.0
0
Year
Ad
ult
s w
ith
atr
ial f
ibr i
ll ati
on
[m
il lio
ns ]
2.08
Go et al, JAMA 2001;285:2370
Prevalence Atrial FibrillationPrevalence Atrial Fibrillation
Heart Rhythm. 2007 Jun;4(6):816-61.
Heart Rhythm. 2007 Jun;4(6):816-61.
HRS/EHRA/ECAS ConsensHRS/EHRA/ECAS Consensus Statementus Statement
Paroxysmal AF: AF (≥2 episodes) that terminates spontaneously within 7 days
Persistent AF: >7 days or cardioversion
Longstanding persistent AF: >12 months continuous AF
Permanent AF: AF has been accepted
Definitions Atrial Fibrillation (AF)
Heart Rhythm. 2007 Jun;4(6):816-61.
HRS/EHRA/ECAS ConsensHRS/EHRA/ECAS Consensus Statementus Statement
Mechanisms of Atrial FibrillationMechanisms of Atrial Fibrillation
Heart Rhythm. 2007 Jun;4(6):816-61.
HRS/EHRA/ECAS ConsensHRS/EHRA/ECAS Consensus Statementus Statement
AF Ablation Strategies
Heart Rhythm. 2007 Jun;4(6):816-61.
AF Ablation StrategiesAF Ablation Strategies
CFAE Definition
Haissaguerre et al. JCE 2005
Heart Rhythm. 2007 Jun;4(6):816-61.
HRS/EHRA/ECAS ConsensHRS/EHRA/ECAS Consensus Statementus Statement
Procedural EProcedural Endpointndpoint
• Wide area circumferential lesions (CCL)Wide area circumferential lesions (CCL)
• Online Lasso recordings to prove PVIOnline Lasso recordings to prove PVI
Ouyang et al. 2004 Circulation Heart Rhythm. 2007
#4#7
#1#9
#9#1
#7#4
Lateral PVs
Ouyang F et al. (Circulation 2004;110:2090–2096)
LSPV
Map CS
His LIPV
LSPV
LIPV
LAA
Pulmonary Vein IsolationPulmonary Vein Isolation
• It is important to recognize that catheter It is important to recognize that catheter ablation of AF is a demanding technical ablation of AF is a demanding technical procedure that may result in complicationsprocedure that may result in complications
• Patients should only undergo AF ablation Patients should only undergo AF ablation after carefully weighing the risks and after carefully weighing the risks and benefits of the procedurebenefits of the procedure
HRS/EHRA/ECAS ConsensHRS/EHRA/ECAS Consensus Statementus Statement
Indications for AF Catheter Ablation
Heart Rhythm. 2007 Jun;4(6):816-61.
HRS/EHRA/ECAS ConsensHRS/EHRA/ECAS Consensus Statementus Statement
• Symptomatic AF refractory ≥ 1 AAD Symptomatic AF refractory ≥ 1 AAD (Class I, III)(Class I, III)
• AF ablation as first line therapy (rare AF ablation as first line therapy (rare clinical situations)clinical situations)
• Selected pts with heart failure and/or Selected pts with heart failure and/or reduced EFreduced EF
Heart Rhythm. 2007 Jun;4(6):816-61.
Indications for AF Catheter Ablation
HRS/EHRA/ECAS ConsensHRS/EHRA/ECAS Consensus Statementus Statement
• Cardiac tamponade (<6%)Cardiac tamponade (<6%)
• Pulmonary vein stenosis (0-38%)Pulmonary vein stenosis (0-38%)
• Atrio-Esophageal fistula (<0.25%)Atrio-Esophageal fistula (<0.25%)
• Phrenic nerve injury (<0.48%)Phrenic nerve injury (<0.48%)
• Thromembolism (0-7%)Thromembolism (0-7%)
• Post procedural arrhythmias (5-25%)Post procedural arrhythmias (5-25%)
• Vascular complications (0-13%)Vascular complications (0-13%)
• Radiation exposureRadiation exposure
Heart Rhythm. 2007 Jun;4(6):816-61.
Complications in AF Ablation
HRS/EHRA/ECAS ConsensHRS/EHRA/ECAS Consensus Statementus Statement
• Heparin Heparin Target ACT 300 to 400s Target ACT 300 to 400s
• Careful identification of PV ostia is mandatoryCareful identification of PV ostia is mandatory
• If additional lesions are applied, line completeness If additional lesions are applied, line completeness should be demonstrated should be demonstrated
• RAI block only in pts with typical or inducible AFLRAI block only in pts with typical or inducible AFL
• Non PV triggers should be targeted if possibleNon PV triggers should be targeted if possible
• If pts with longstanding persistent AF are If pts with longstanding persistent AF are approached, ostial PVI may not be sufficentapproached, ostial PVI may not be sufficent
Heart Rhythm. 2007 Jun;4(6):816-61.
Technique / Lab Managements
HRS/EHRA/ECAS ConsensHRS/EHRA/ECAS Consensus Statementus Statement
• F/U visits; 3 months, 9 months and then every 6 F/U visits; 3 months, 9 months and then every 6 months for at least 2 yearsmonths for at least 2 years
• Event monitor in pts who complain of Event monitor in pts who complain of palpitationspalpitations
• AF/AFL/AT >30s are treatment failuresAF/AFL/AT >30s are treatment failures
• 24h HOLTER is acceptable for minimal 24h HOLTER is acceptable for minimal monitoring for pts in clinical trials and is monitoring for pts in clinical trials and is recommended at 3 to 6 months intervals for 1 to recommended at 3 to 6 months intervals for 1 to 2 years2 years
Heart Rhythm. 2007 Jun;4(6):816-61.
Minimal Monitoring
• 1. Procedure:1. Procedure: Wide area circumferential Wide area circumferential PVI of ipsilateral PVsPVI of ipsilateral PVs
• 2. Procedure:2. Procedure: Re-check PV conduction: Re-check PV conduction: Gap closureGap closure
– Clinical AT Clinical AT Ablation Ablation
• 3. Procedure:3. Procedure: CFAE identification and CFAE identification and ablation (LA, CS, RA)ablation (LA, CS, RA)
– Clinical AT Clinical AT Ablation Ablation
Hamburg AF Ablation Approach
• Catheter ablation of AF is...Catheter ablation of AF is...
– performed throughout the worldperformed throughout the world
– associated with high success ratesassociated with high success rates
– significant complicationssignificant complications
• PV isolation is cornerstone of AF ablationPV isolation is cornerstone of AF ablation
HRS/EHRA/ECAS ConsensHRS/EHRA/ECAS Consensus Statementus Statement
Conclusion